[D1-A2] Advances and Challenges in Bioanalysis of Oligonucleotide Therapeutics | 17th JBF Symposium

Advanced Search

Session Details

SymposiumSymposium : Oligonucleotide

[D1-A2]Advances and Challenges in Bioanalysis of Oligonucleotide Therapeutics

Wed. Mar 4, 2026 1:25 PM - 2:40 PM JST
Wed. Mar 4, 2026 4:25 AM - 5:40 AM UTC

Medium Hall(2nd Floor)

Chairman:Makoto Takahashi(Daiichi Sankyo Co., Ltd.), Miyuki Ugajin(Takeda Pharmaceutical Co., Ltd.)

1:25 PM - 1:50 PM JST(4:25 AM - 4:50 AM UTC)

[D1-A2-01]Development and Validation of LC–MS-Based Bioanalytical Methods for Oligonucleotide Therapeutics: Points to Consider

*Yuchen Sun¹, Shin-ichiro Nitta², Ryoya Goda³, Yuki Kishino⁴, Hisashi Fujita⁵, Masaaki Kakehi⁵, Yoshiharu Hayashi⁶, Satoshi Ito⁷, Tomomi Ishida⁸, Kiyomi Kikuchi⁸, Kazuko Inoue⁸, Kazutaka Shimbo⁹, Takeru Yamaguchi¹⁰, Fumihiro Jinno¹¹, Kaori Murakoshi¹², Kentaro Takahara¹³, Chie Murata¹⁴, Mitsuhiko Kawabata¹⁵, Kosuke Saito¹, Ruri Hanajiri¹, Yoshiro Saito¹ (1. National Institute of Health Sciences, 2. Mediford Corporation, 3. Future Peak Co., Ltd., 4. Daiichi Sankyo Co., Ltd., 5. Takeda Pharmaceutical Co., Ltd., 6. CMIC Pharma Science Co., Ltd., 7. Sekisui Medical Co., Ltd., 8. Eisai Co., Ltd., 9. Ajinomoto Co., Inc., 10. Sumika Chemical Analysis Service, Ltd., 11. Axcelead Drug Discovery Partners, Inc., 12. Tanabe Pharma Corporation, 13. Thermo Fisher Scientific K.K., 14. Ono Pharmaceutical Co., Ltd., 15. Shin Nippon Biomedical Laboratories, Ltd.)

Comment()

1:50 PM - 2:15 PM JST(4:50 AM - 5:15 AM UTC)

[D1-A2-02]PAC-LC-MS/MS Tissue Bioanalysis of Oligonucleotide Therapeutics: ICH M10–Based Validation and Multi-center Standardization

*Shin-ichiro Nitta¹, Yuchen Sun², Ryoya Goda³, Yuki Kishino⁴, Xiaoxi Liu⁵, Hisashi Fujita⁵, Masaaki Kakehi⁵, Yoshiharu Hayashi⁶, Satoshi Ito⁷, Tomomi Ishida⁸, Kiyomi Kikuchi⁸, Kazuko Inoue⁸, Kazutaka Shimbo⁹, Takeru Yamaguchi¹⁰, Fumihiro Jinno¹¹, Kaori Murakoshi¹², Kentaro Takahara¹³, Chie Murata¹⁴, Mitsuhiko Kawabata¹⁵, Kosuke Saito², Ruri Hanajiri², Yoshiro Saito² (1. Mediford Corporation, 2. National Institute of Health Sciences, 3. Future Peak Co., Ltd., 4. Daiichi Sankyo Co., Ltd., 5. Takeda Pharmaceutical Co., Ltd., 6. CMIC Pharma Science Co., Ltd., 7. Sekisui Medical Co., Ltd., 8. Eisai Co., Ltd., 9. Ajinomoto Co., Inc., 10. Sumika Chemical Analysis Service, Ltd., 11. Axcelead Drug Discovery Partners, Inc., 12. Tanabe Pharma Corporation, 13. Thermo Fisher Scientific K.K., 14. Ono Pharmaceutical Co., Ltd., 15. Shin Nippon Biomedical Laboratories, Ltd.)

Comment()

2:15 PM - 2:40 PM JST(5:15 AM - 5:40 AM UTC)

[D1-A2-03]Challenges and Analytical Considerations in Protein Binding Studies for Nucleic Acid Therapeutics

*Kenichi Maeda¹, Rieko Sakai¹, Shun Kumagaya², Kosuke Chiba², Takao Suzuki², Kenta Hashizume¹ (1. SEKISUI MEDICAL CO., LTD., 2. Luxna Biotech Co., Ltd.)

Comment()

Back to Category List